RECRUITING

INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective, randomized, non-blinded study comparing CINB plus medical therapy versus standard medical care (non-steroidals and opioids intravenous/oral inpatient and oral outpatient) alone for patients with multiple rib fractures. The objective of this study is to analyze the effect of continuous intercostal nerve block (CINB) in the treatment of patients admitted to the adult trauma service with rib fractures. The effectiveness of CINB as adjunctive treatment will be compared to standard medical therapy involving nonsteroidal and intravenous/oral opioid medications.

Official Title

The Efficacy of Continuous Intercostal Nerve Blocks in the Treatment of Patients With Multiple Rib Fractures

Quick Facts

Study Start:2024-12-01
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05642026

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subjects will be at least 18 years old
  2. * Subjects will have 2 or more identified rib fractures
  3. * Subjects will be willing to provide informed consent for procedure
  4. * Subjects will be identified as appropriate for initiation of continuous nerve block therapy for treatment of rib fracture associated pain.
  1. * Documented allergy to study medication
  2. * Epidural catheter use
  3. * Prisoners
  4. * Refusal of CINB therapy

Contacts and Locations

Principal Investigator

Zachary Warriner, MD
PRINCIPAL_INVESTIGATOR
University of Kentucky

Study Locations (Sites)

University of Kentucky Medical Center
Lexington, Kentucky, 40536
United States

Collaborators and Investigators

Sponsor: Zachary Warriner

  • Zachary Warriner, MD, PRINCIPAL_INVESTIGATOR, University of Kentucky

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-01
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2024-12-01
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • intercostal
  • nerve block
  • opioid
  • non steroidal
  • inpatient
  • outpatient
  • catheter
  • anesthetic
  • epidural

Additional Relevant MeSH Terms

  • Rib Fractures